Amlodipine Besylate
Product Images NDC 55648-421

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 55648-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Amlodipine Tablets 10 mg 1000 Tablets Label)

Label for Amlodipine Besylate Tablets 10 mg, displayed on a 1000-tablet container. The label includes product name, strength, NDC 64679-423-02, and is marked Rx only. The label also shows storage instructions, manufacturer Wockhardt Limited, distributor Wockhardt USA LLC, and barcode. Dimensions are 150 mm by 65 mm.*

FDA Label Image

Blister (Amlodipine Tablets 10 mg Unit Dose Blister)

Amlodipine Besylate Tablet 10 mg blister card labeling showing packaging information for ten tablets. The label includes the National Drug Code (NDC) 64679-423-03 and states the product is manufactured by Wockhardt Limited in India and distributed by Wockhardt USA LLC in Parsippany, NJ, USA. Spaces for lot number and expiration date are provided but not filled in.*

FDA Label Image

Carton (Amlodipine Tablets 10 mg Unit Dose Carton)

Carton for Amlodipine Besylate Tablets, 10 mg by Wockhardt Limited. The label states 'Amlodipine Besylate Tablets 10 mg' and specifies the package contains 100 unit dose tablets. Storage instructions advise room temperature between 20°-25°C. The carton includes NDC 64679-423-03 and indicates prescription-only status. Manufacturer and distributor details are provided, with a barcode displayed on one panel.*

FDA Label Image

Amlodipine Tablets_figure01 (Amlodipine Tablets Figure01)

A Kaplan-Meier survival curve showing event rates over 24 months comparing Amlodipine versus placebo. The graph includes a p-value (0.003), hazard ratio (0.691), and 95% confidence interval (0.54, 0.88), with numbers at risk indicated below the x-axis at various time points.*

FDA Label Image

Amlodipine Tablets_figure02 (Amlodipine Tablets Figure02)

A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across various patient subgroups, including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis represents the hazard ratio ranging from 0 to 2, with a reference line at 1. The plot illustrates subgroup efficacy or risk trends for Amlodipine versus placebo.*

FDA Label Image

Structure (Amlodipine Tablets Structure)

Chemical structure diagram of Amlodipine Besylate showing its molecular framework, including aromatic rings, chlorine atom, ester groups, and amino group attached to the main structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.